Cepharanthin Enhances Cisplatin Sensitivity for Cisplatin-Resistant Oral Squamous Cell Carcinoma Cell Lines

Nakatani, Ken; Wada, Takuro; Tajima, Takuya; Hiraishi, Yukihiro; Negoro, Kohei; Yabuta, Tatsuo; Fujita, Shigeyuki

doi:10.5981/jjhnc.32.1

Toukeibu Gan

2006

DOI: 10.5981/jjhnc.32.1

|View full text |Cite

Cepharanthin Enhances Cisplatin Sensitivity for Cisplatin-Resistant Oral Squamous Cell Carcinoma Cell Lines

Ken Nakatani¹,

Takuro Wada²,

Takuya Tajima³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2007

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

A case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy

健¹,

現²,

健二³

et al. 2007

Toukeibu Gan

View full text Add to dashboard Cite

要旨転移性の唾液腺癌に対し，化学療法(TPFL-セファランチン)と放射線療法を併用し，良好な結果を得た。患者は 68 キーワード：顎下腺，扁平上皮癌，胸鎖関節部転移，化学・放射線療法，TPFL-セファランチンA case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy :

show abstract

A case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy

健¹,

現²,

健二³

et al. 2007

Toukeibu Gan

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Cepharanthin Enhances Cisplatin Sensitivity for Cisplatin-Resistant Oral Squamous Cell Carcinoma Cell Lines

Cited by 1 publication

References 15 publications

A case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy

A case of metastatic carcinoma from a primary tumor of the submandibular gland (SqCC) to the sternoclavicular joint region successfully treated with concurrent chemotherapy (TPFL-Cepharanthine) and radiation therapy

Contact Info

Product

Resources

About